IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation

Ítems similars

• Constitutively active Stat5b in CD4(+) T cells inhibits graft-versus-host disease lethality associated with increased regulatory T-cell potency and decreased T effector cell responses
  per: Vogtenhuber, Christine, et al.
  Publicat: (2010)
• Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality
  per: Jasperson, Lisa K., et al.
  Publicat: (2009)
• Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality
  per: Jasperson, Lisa K., et al.
  Publicat: (2008)
• Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells
  per: Veenstra, Rachelle G., et al.
  Publicat: (2012)
• Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD)
  per: Taylor, Patricia A., et al.
  Publicat: (2007)